Related Experiment Videos
Phenobarbitone dosage in neonatal convulsions
Insights
Finding the optimal phenobarbitone dosage for neonatal convulsions is crucial. A loading dose of 15 mg/kg safely achieved therapeutic levels within 2 hours, maintained by 6 mg/kg daily.
Area of Science:
- Neonatal Medicine
- Pharmacology
- Clinical Therapeutics
Background:
- Neonatal seizures are a common emergency requiring prompt treatment.
- Phenobarbitone is a first-line anticonvulsant for neonatal convulsions.
- Determining optimal dosing regimens is essential for efficacy and safety.
Purpose of the Study:
- To investigate the optimal dosage schedule of phenobarbitone for treating neonatal convulsions.
- To establish safe and effective loading and maintenance doses for phenobarbitone in neonates.
Main Methods:
- Four groups of infants received different phenobarbitone dosage regimens (intramuscular and intravenous routes).
- Phenobarbitone blood levels were monitored regularly.
- Gas liquid chromatography was used to determine phenobarbitone concentrations.
Main Results:
- A mean intravenous or intramuscular loading dose of 15 mg/kg achieved therapeutic phenobarbitone levels within 2 hours.
- A maintenance dose of 6 mg/kg per day effectively sustained high therapeutic levels.
- Different initial dosing strategies showed varying pharmacokinetic profiles.
Conclusions:
- A loading dose of approximately 15 mg/kg of phenobarbitone is recommended for rapid achievement of therapeutic levels in neonatal convulsions.
- A daily maintenance dose of 6 mg/kg ensures sustained therapeutic concentrations.
- This dosing strategy provides a safe and effective treatment for neonatal seizures.
Abstract:
In order to find the optimal dosage schedule of phenobarbitone for neonatal convulsions, four groups of patients were studied. Twelve infants (group 1) received a mean phenobarbitone dose of 9.5 mg/kg a day given intramuscularly for 3 days followed by 5.8 mg/kg a day given intramuscularly and then orally. Six infants (group 2) received a mean intravenous loading dose of 9.5 mg/kg followed by 6.8 mg/kg a day given intramuscularly or orally. Nine infants (group 3) received a mean loading dose of 14.9 mg/kg intravenously followed by a maintenance dose of 5.9 mg/kg a day. Thirteen patients (group 4) received a mean intramuscular loading dose of 15.2 mg/kg followed by 5.9 mg/kg a day. Blood samples were taken regularly and phenobarbitone levels were determined by gas liquid chromatography. A mean intravenous or intramuscular loading dose of 15 mg/kg of phenobarbitone safely achieved therapeutic levels within 2 hours of injection and high therapeutic levels were maintained with a dose of 6 mg/kg a day.